- Home
- ZKH vs ARCT Comparison
ZKH vs ARCT Comparison
Compare ZKH & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZKH
- ARCT
- Stock Information
- Founded
- ZKH 1998
- ARCT 2013
- Country
- ZKH China
- ARCT United States
- Employees
- ZKH N/A
- ARCT N/A
- Industry
- ZKH
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- ZKH
- ARCT Health Care
- Exchange
- ZKH Nasdaq
- ARCT Nasdaq
- Market Cap
- ZKH 462.2M
- ARCT 526.5M
- IPO Year
- ZKH 2023
- ARCT N/A
- Fundamental
- Price
- ZKH $3.03
- ARCT $11.20
- Analyst Decision
- ZKH
- ARCT Buy
- Analyst Count
- ZKH 0
- ARCT 10
- Target Price
- ZKH N/A
- ARCT $35.25
- AVG Volume (30 Days)
- ZKH 13.7K
- ARCT 2.1M
- Earning Date
- ZKH 11-21-2025
- ARCT 11-07-2025
- Dividend Yield
- ZKH N/A
- ARCT N/A
- EPS Growth
- ZKH N/A
- ARCT N/A
- EPS
- ZKH N/A
- ARCT N/A
- Revenue
- ZKH $1,221,845,808.00
- ARCT $122,122,000.00
- Revenue This Year
- ZKH $5.54
- ARCT N/A
- Revenue Next Year
- ZKH $9.38
- ARCT $34.32
- P/E Ratio
- ZKH N/A
- ARCT N/A
- Revenue Growth
- ZKH N/A
- ARCT N/A
- 52 Week Low
- ZKH $2.50
- ARCT $8.04
- 52 Week High
- ZKH $4.07
- ARCT $24.17
- Technical
- Relative Strength Index (RSI)
- ZKH 56.15
- ARCT 32.09
- Support Level
- ZKH $2.80
- ARCT $9.19
- Resistance Level
- ZKH $3.06
- ARCT $12.10
- Average True Range (ATR)
- ZKH 0.12
- ARCT 1.81
- MACD
- ZKH 0.01
- ARCT -1.24
- Stochastic Oscillator
- ZKH 84.62
- ARCT 13.44
About ZKH ZKH Group Limited each representing thirty-five (35)
ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. All of the Group's revenues are derived from the PRC.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.